Morris G, Vlachostergios PJ, Rai MP, Scherr D, Molina A, Elemento O, Mosquera JMiguel, Cheng L, Faltas BM.
2026.
19q13 amplification with AKT2 and ERCC2 gains in sarcomatoid carcinoma of the urinary bladder.. Cancer Genet. 304-305:51-57.
Bai Y, Agustinus AS, Yomtoubian S, Meydan C, McNally DR, Yoffe L, Hubisz MJ, Tranquille M, Pramod S, Hong C et al..
2026.
Epigenetic Regulation of Chromosomal Instability by EZH2 Methyltransferase.. Cancer Discov. 16(1):135-154.
Umesh A, Cordogan S, Simpson SK, Bram JT, Jones RH, Schairer WW, Sboner A, Elemento O, Green DW, Fabricant PD.
2026.
Genetic Variants Related to TGF-β Signaling Pathway Modulate Risk of Meniscus Injury: A Multiancestry Genome-wide Association Study.. Clin Orthop Relat Res. 484(1):178-193.
Okur V, Marcus A, Falcone JN, Hurd MA, Stewart SL, Claudio K, Manohar J, Dealla F, Kumar S, Yeung M et al..
2026.
Genome sequencing identifies monogenic causes in adults with metabolic diseases.. J Endocr Soc. 10(7):bvag091.
Uppal M, Bhinder B, Marderstein AR, Batlevi CLee, Falchi L, Hamlin P, Horwitz S, Kumar A, Noy A, Zelenetz AD et al..
2026.
Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in TP53-Mutated Diffuse Large B-Cell Lymphoma.. J Clin Oncol. :JCO2501928.
Ruan J, Bond DA, Shah B, Allan JN, Rutherford SC, Gribbin C, Chen Z, Bhinder B, Tam W, Rossi D et al..
2026.
MRD-driven initial therapy of acalabrutinib and lenalidomide plus rituximab or obinutuzumab for mantle cell lymphoma.. Blood Adv. 10(4):1381-1394.
Nazzaro M, Mardis ER, Canella A, Bhinder B, Elemento O, Behbehani G, Currier M, Glaspell A, Lee DA, Cripe TP et al..
2026.
Trabectedin decreases myeloid resistance to improve the efficacy of anti-PD1 immunotherapy and delay glioma malignant progression.. Mol Ther Oncol. 34(1):201147.
Podaza E, Capuano J, Kuo H-H, Assaad MAl, Markowitz G, M Revuelta V, Nguyen J, Irizarry A, Ravichandran H, Ackermann S et al..
2026.
Tumor immune microenvironment reconstitution in patient-derived organoids enables therapy modeling for NSCLC.. Cell Rep Methods. :101339.
Purkayastha S, Park J, Beyer S, Chandra A, Markowitz SM, Lerman BB, Elemento O, Krumsiek J, Lo JC, Cheung JW.
2026.
Utilization of Serum Metabolomics and Polygenic Risk Scores in a Novel Risk Stratification Tool for the Prediction of Incident Atrial Fibrillation.. Circ Arrhythm Electrophysiol. :e013858.
Assaad MAl, Hadi K, Levine MF, Guevara D, Patel M, Tranquille M, King A, Otilano J, Semaan A, Gundem G et al..
2026.
Whole genome sequencing approach to assess homologous recombination deficiency in a pan-cancer cohort.. Commun Med (Lond). 6(1):5.
Kozan ENur, de la Mora JDelgado-, Assaad MAl, Ginter P, Gundem G, Levine MF, Gorski K, Phan A, Beg S, Sigaras A et al..
2026.
Whole genome sequencing of locally advanced and metastatic breast carcinoma unravels relevant molecular signatures and novel events.. Pathol Res Pract. 282:156469.